EIPC Workshop on PCB BioMEMS


Reading time ( words)

The Premier Inn conference centre at Heathrow Airport was the venue for the EIPC workshop on PCB BioMEMS. What, I hear you ask, is a PCB BioMEMS? This is an abbreviation for biomedical (or biological) microelectromechanical systems, otherwise known as lab-on-chip.

Given the strong market pull for more BioMEMS devices (USD $2.5 billion in 2014 and anticipated to grow at CAGR of more than 25% from 2016 to 2023), the commercialization of lab-on-chip devices is currently the Holy Grail of the research community. The lab-on-PCB approach (aka PCB BioMEMS) is being followed in various research groups all over Europe, owing to its inherent upscaling potential: the PCB industry is well-established all around the world, with standardized fabrication facilities and processes is currently commercially exploited only for electronics.

The workshop began with an introduction from Dr. Despina Moschou, 50th Anniversary Prize Fellow/Lecturer at the Centre for Advanced Sensor Technologies at the University of Bath. It was Despina who first introduced the concept of PCB BioMEMS to the EIPC at its Summer Conference in Edinburgh in June 2016, which ignited interest. She asked why lab-on-chip is not already more established using PCB technologies to provide the needed integration between the microfluidics, the biological elements and the electronics required to form an analytical system highlighting the long-standing industrial infrastructure, microfabrication capabilities and intuitive integration of electronics.

The first speaker was Dr. Yuksel Temiz of IBM’s Zurich Research Laboratory. Dr. Temiz explained that although there are over 1,400+ infectious species and 347 significant diseases, less than 5% of their prevalence has been accurately mapped. He postulated that the use of IoT-based devices linked to Smartphones or a handheld reader could revolutionise infectious disease mapping. He contrasted conventional lateral  flow technology, such as that used in pregnancy detectors noting that microfluidics technology would require a much smaller sample size and optimised flow control to give much better quantitative results when used in a portable immunodiagnostic microfluidic platform.

To read the full version of this article which appeared in the February 2017 issue of The PCB Magazine, click here.

Share


Suggested Items

Show & Tell: IPC APEX EXPO 2018 Opening Keynote Review

04/04/2018 | Pete Starkey, I-Connect007
The first keynote speech of IPC APEX EXPO 2018 was presented by Jared Cohen, head of Google’s Jigsaw team of engineers, researchers, and geopolitical experts. He explained that Jigsaw builds products not only to tackle global security challenges, but also to support free expression and access to information, especially in repressive societies.

Weiner’s World—March 2018

04/03/2018 | Gene Weiner, Weiner International Inc.
SEMICON China 2018 was amazing in its size and attendance. More than 1,000 exhibitors filled an event record of more than 74,000 square meters of exhibition space—the size of nearly 10 professional soccer fields. This year's theme was "collect, collaborate, innovate."

Weiner’s World—December 2017

01/02/2018 | Gene Weiner, Weiner International Inc.
Hold on to your seats! 2018 will be a year full of rapid changes, surprises, and growth. M&A activities will flourish. The supply chain will suffer shortages and changes as demand increases, copycats will rush to market, and new markets and potential suppliers will vanish before they are established.



Copyright © 2018 I-Connect007. All rights reserved.